These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107. Ethnic diversity in treatment response for colorectal cancer: proof of concept for radiomics-driven enrichment trials. Dercle L; Yang M; Gönen M; Flynn J; Moskowitz CS; Connors DE; Yang H; Lu L; Reidy-Lagunes D; Fojo T; Karovic S; Zhao B; Schwartz LH; Henick BS Eur Radiol; 2023 Dec; 33(12):9254-9261. PubMed ID: 37368111 [TBL] [Abstract][Full Text] [Related]
108. Towards evidence-based response criteria for cancer immunotherapy. Garralda E; Laurie SA; Seymour L; de Vries EGE Nat Commun; 2023 May; 14(1):3001. PubMed ID: 37225715 [TBL] [Abstract][Full Text] [Related]
109. Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy. Dercle L; McGale J; Sun S; Marabelle A; Yeh R; Deutsch E; Mokrane FZ; Farwell M; Ammari S; Schoder H; Zhao B; Schwartz LH J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36180071 [TBL] [Abstract][Full Text] [Related]
110. Radiation and immune checkpoint inhibitor-mediated pneumonitis risk stratification in patients with locally advanced non-small cell lung cancer: role of functional lung radiomics? Thomas HMT; Hippe DS; Forouzannezhad P; Sasidharan BK; Kinahan PE; Miyaoka RS; Vesselle HJ; Rengan R; Zeng J; Bowen SR Discov Oncol; 2022 Sep; 13(1):85. PubMed ID: 36048266 [TBL] [Abstract][Full Text] [Related]
111. The expanding role for small molecules in immuno-oncology. Offringa R; Kötzner L; Huck B; Urbahns K Nat Rev Drug Discov; 2022 Nov; 21(11):821-840. PubMed ID: 35982333 [TBL] [Abstract][Full Text] [Related]
112. Assessing dynamic metabolic heterogeneity in non-small cell lung cancer patients via ultra-high sensitivity total-body [ Wang D; Zhang X; Liu H; Qiu B; Liu S; Zheng C; Fu J; Mo Y; Chen N; Zhou R; Chu C; Liu F; Guo J; Zhou Y; Zhou Y; Fan W; Liu H Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4692-4704. PubMed ID: 35819498 [TBL] [Abstract][Full Text] [Related]
113. Computer-aided detection and segmentation of malignant melanoma lesions on whole-body Dirks I; Keyaerts M; Neyns B; Vandemeulebroucke J Comput Methods Programs Biomed; 2022 Jun; 221():106902. PubMed ID: 35636357 [TBL] [Abstract][Full Text] [Related]
114. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts Tumor Immune Profiles in Non-Small Cell Lung Cancer: A Retrospective Multicohort Study. Tong H; Sun J; Fang J; Zhang M; Liu H; Xia R; Zhou W; Liu K; Chen X Front Immunol; 2022; 13():859323. PubMed ID: 35572597 [TBL] [Abstract][Full Text] [Related]
115. Prognostic Value of Radiomic Features of Zhou Y; Li J; Zhang X; Jia T; Zhang B; Dai N; Sang S; Deng S Front Oncol; 2022; 12():834288. PubMed ID: 35198451 [TBL] [Abstract][Full Text] [Related]
116. Toward Generalizability in the Deployment of Artificial Intelligence in Radiology: Role of Computation Stress Testing to Overcome Underspecification. Eche T; Schwartz LH; Mokrane FZ; Dercle L Radiol Artif Intell; 2021 Nov; 3(6):e210097. PubMed ID: 34870222 [TBL] [Abstract][Full Text] [Related]
117. A Novel Approach Using FDG-PET/CT-Based Radiomics to Assess Tumor Immune Phenotypes in Patients With Non-Small Cell Lung Cancer. Zhou J; Zou S; Kuang D; Yan J; Zhao J; Zhu X Front Oncol; 2021; 11():769272. PubMed ID: 34868999 [TBL] [Abstract][Full Text] [Related]